Errata - English

In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 1/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 3/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Folic Acid, Method 3; Ascorbic Acid, Niacin or Niacinamide, Pyridoxine Hydrochloride, Calcium Pantothenate, Riboflavin, and Thiamine, Method 4/Analysis: Add
ascorbic acid (C₆H₈O₆),

In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 1/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 3/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Folic Acid Method 3; Ascorbic Acid, Niacin or Niacinamide, Pyridoxine Hydrochloride, Calcium Pantothenate, Riboflavin, and Thiamine, Method 4/Analysis: Add
ascorbic acid (C₆H₈O₆),
AND
In Molybdenum, Method 2/Instrumental conditions: Change
(See Atomic Absorption Spectroscopy <852>.)
to:
(See Ultraviolet-Visible Spectroscopy <857>.)

In System suitability/Suitability requirements/Peak-to-valley ratio: Change
NLT 1.5 for loperamide related compounds G and H; NLT 1.5 for loperamide related compounds E and A, System suitability solution
to:
NLT 1.5 for loperamide cis-N-oxide and anhydroloperamide; NLT 1.5 for loperamide piperidinolamide and loperamide biphenyl analog, System suitability solution

In Dissolution <711>: Change
Sample solution: Sample per the chapter. Dilute with Medium to a concentration that is similar to the Standard solution.
Tolerances: NLT 75% (Q) of the labeled amount of dicloxacillin (C₁₉H₁₇Cl₂N₃O₅S) is dissolved.
to:
Sample solution: Sample per the chapter. Pass a portion of the solution under test through a suitable filter. Dilute with Medium to a concentration that is similar to the Standard solution.
Instrumental conditions
Mode: UV-Vis
Tolerances: NLT 75% (Q) of the labeled amount of dicloxacillin (C₁₉H₁₇Cl₂N₃O₅S) is dissolved.

In Test 1/Analysis: Change
dissolved at time point (i):
Result_i = (r_U/r_S) × C_S × V × D × (1/L) × 100
to:
dissolved:
Result = (r_U/r_S) × C_S × V × D × (1/L) × 100
AND
In Test 3/Analytical procedure 1/Analysis: Change
V = volume of Medium, 900 mL
to:
V = volume of Medium 1, 900 mL
AND
In Test 3/Analytical procedure 2/Analysis: Change
V_M = volume of Medium, 900 mL
to:
V_M = volume of Medium 1, 900 mL
AND
In Test 3/Analytical procedure 3/Blank: Change
Medium
to:
Medium 2
AND
In Test 3/Analytical procedure 3/Analysis: Change
V_M = volume of Medium, 900 mL
to:
V_M = volume of Medium 2, 900 mL

In all instances in Table 4: Change
<
to:
≤
AND
In Control of Photometric Response/Acidic Nicotinic Acid Solutions in 0.1 N Hydrochloric Acid/paragraph 1: Change
Using nicotinic acid solutions, the absorbance accuracy must be ± 0.01 A_λ.
to:
Using nicotinic acid solutions, the absorbance accuracy must be ± 0.010 A_λ (for values below 1.00 A_λ).

In Standard stock solution: Change
of USP Insulin RS of the appropriate species
to:
of the USP Insulin Reference Standard of the appropriate species
AND
In Sample stock solution: Change
of USP Insulin RS of the appropriate species.
to:
of the USP Insulin Reference Standard of the appropriate species.

In Standard solution: Change
USP Simvastatin RS in Medium
to:
USP Simvastatin RS in Medium. Transfer a portion of the solution to a centrifuge tube containing about 10 mg of Prewashed manganese dioxide per milliliter of transferred solution under test, and mix. Allow the mixture to stand for 30 min with occasional shaking, centrifuge, and use a portion of the clear supernatant.

Change
Solution A, Mobile phase, Standard solution, Sample solution, Chromatographic system, and System suitability: Proceed as directed in the Assay, making any necessary volumetric adjustments.
to:
Solution A, Mobile phase, Standard solution, Chromatographic system, and System suitability: Proceed as directed in the Assay, making any necessary volumetric adjustments.
Sample solution: Take a portion of the solution under test, and dilute if necessary.

Change
Standardization: Add 2 drops of phenolphthalein TS to 20 mL of 0.1 N potassium hydroxide VS. Titrate with 0.1 N hydrochloric acid VS until a permanent pale-pink color is produced.
to:
Standardization: Add 2 drops of phenolphthalein TS to 20 mL of 0.1 N hydrochloric acid VS. Titrate with the potassium hydroxide solution until a permanent pale-pink color is produced.

In Test 2 and Test 3 in Analysis: Change
Result₁ = C₁ × (1/L) × (M_r1/M_r2) × 100
to:
Result₁ = C₁ × V × (1/L) × (M_r1/M_r2) × 100